WO2011033506A3 - Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage - Google Patents
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage Download PDFInfo
- Publication number
- WO2011033506A3 WO2011033506A3 PCT/IL2010/000754 IL2010000754W WO2011033506A3 WO 2011033506 A3 WO2011033506 A3 WO 2011033506A3 IL 2010000754 W IL2010000754 W IL 2010000754W WO 2011033506 A3 WO2011033506 A3 WO 2011033506A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pon1
- isolated
- polypeptides
- treating
- polynucleotides encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Abstract
An isolated polypeptide comprising the amino acid sequence of serum paraoxonase (PON1) having catalytic efficiency of k
cat /K M ≈106 M-1min-1 for a nerve-agent substrate.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10768078A EP2478093A2 (en) | 2009-09-17 | 2010-09-15 | Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
IL218613A IL218613A0 (en) | 2009-09-17 | 2012-03-13 | Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
US13/420,920 US8735124B2 (en) | 2009-09-17 | 2012-03-15 | Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27236309P | 2009-09-17 | 2009-09-17 | |
US61/272,363 | 2009-09-17 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/420,920 Continuation-In-Part US8735124B2 (en) | 2009-09-17 | 2012-03-15 | Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2011033506A2 WO2011033506A2 (en) | 2011-03-24 |
WO2011033506A9 WO2011033506A9 (en) | 2011-05-05 |
WO2011033506A3 true WO2011033506A3 (en) | 2011-09-29 |
Family
ID=43589971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2010/000754 WO2011033506A2 (en) | 2009-09-17 | 2010-09-15 | Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2478093A2 (en) |
WO (1) | WO2011033506A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8735124B2 (en) * | 2009-09-17 | 2014-05-27 | Yeda Research And Development Co. Ltd. | Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage |
WO2013040501A1 (en) | 2011-09-16 | 2013-03-21 | Pharmathene, Inc. | Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078991A2 (en) * | 2003-03-04 | 2004-09-16 | Yeda Research And Development Co. Ltd. | Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
WO2007105223A2 (en) * | 2006-03-16 | 2007-09-20 | Yeda Research And Development Co. Ltd. | Methods of diagnosing pon1-hdl associated lipid disorders |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154600B (en) | 1971-02-10 | 1977-09-15 | Organon Nv | METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES. |
NL154598B (en) | 1970-11-10 | 1977-09-15 | Organon Nv | PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING. |
NL154599B (en) | 1970-12-28 | 1977-09-15 | Organon Nv | PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING. |
US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
NL171930C (en) | 1972-05-11 | 1983-06-01 | Akzo Nv | METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING. |
US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
WO2000064539A1 (en) | 1999-04-26 | 2000-11-02 | U.S. Army Medical Research And Materiel Command | Method to make op detoxifying sponges |
US20040109853A1 (en) | 2002-09-09 | 2004-06-10 | Reactive Surfaces, Ltd. | Biological active coating components, coatings, and coated surfaces |
-
2010
- 2010-09-15 EP EP10768078A patent/EP2478093A2/en not_active Withdrawn
- 2010-09-15 WO PCT/IL2010/000754 patent/WO2011033506A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078991A2 (en) * | 2003-03-04 | 2004-09-16 | Yeda Research And Development Co. Ltd. | Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
WO2007105223A2 (en) * | 2006-03-16 | 2007-09-20 | Yeda Research And Development Co. Ltd. | Methods of diagnosing pon1-hdl associated lipid disorders |
Non-Patent Citations (6)
Title |
---|
AHARONI AMIR ET AL: "Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US, vol. 101, no. 2, 13 January 2004 (2004-01-13), pages 482 - 487, XP002438727, ISSN: 0027-8424, DOI: DOI:10.1073/PNAS.2536901100 * |
ASHANI Y ET AL: "Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers", CHEMICO-BIOLOGICAL INTERACTIONS, ELSEVIER SCIENCE IRLAND, IR, vol. 187, no. 1-3, 6 September 2010 (2010-09-06), pages 362 - 369, XP027174373, ISSN: 0009-2797, [retrieved on 20100319] * |
BAJGAR JIRÍ: "Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment", ADVANCES IN CLINICAL CHEMISTRY, ACADEMIC PRESS, LONDON, GB, vol. 38, 1 January 2004 (2004-01-01), pages 151 - 216, XP009109278, ISSN: 0065-2423, DOI: DOI:10.1016/S0065-2423(04)38006-6 * |
GUPTA RINKOO D ET AL: "Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.", NATURE CHEMICAL BIOLOGY FEB 2011 LNKD- PUBMED:21217689, vol. 7, no. 2, February 2011 (2011-02-01), pages 120 - 125, XP002627100, ISSN: 1552-4469 * |
HAREL M ET AL: "Structure and evolution of the serum paraoxonase family of detoxifying and antiatherosclerotic enzymes", NATURE STRUCTURAL & MOLECULAR BIOLOGY NATURE PUBLISHING GROUP USA, vol. 11, no. 5, May 2004 (2004-05-01), pages 412 - 419, XP002627099, ISSN: 1545-9993 * |
ROCHU ET AL: "Human paraoxonase: A promising approach for pre-treatment and therapy of organophosphorus poisoning", TOXICOLOGY, LIMERICK, IR, vol. 233, no. 1-3, 31 March 2007 (2007-03-31), pages 47 - 59, XP022012211, ISSN: 0300-483X, DOI: DOI:10.1016/J.TOX.2006.08.037 * |
Also Published As
Publication number | Publication date |
---|---|
WO2011033506A2 (en) | 2011-03-24 |
WO2011033506A9 (en) | 2011-05-05 |
EP2478093A2 (en) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500528A1 (en) | Fc containing polypeptides with altered glycosylation and reduced | |
WO2007035600A3 (en) | Natriuretic activities | |
WO2006103666A3 (en) | Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis | |
WO2009042237A3 (en) | Methods and compositions for modulating bcl-2 family polypeptides | |
NZ591855A (en) | Novel immunotherapy against several tumors including neuronal and brain tumors | |
JP2013510581A5 (en) | ||
EA201170878A1 (en) | POLYPEPTIDES WITH XYLANASE ACTIVITY | |
WO2008070082A3 (en) | Stem-progenitor cell specific micro-ribonucleic acids and uses thereof | |
WO2006066024A8 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
WO2007148224A3 (en) | Polypeptide | |
WO2013052946A3 (en) | Genetically encoded biosensors | |
ATE453664T1 (en) | HOUSE DUST MITE ALLERGEN | |
WO2010031988A3 (en) | Polypeptides substrates of lrrk2 and uses thereof | |
WO2011056954A3 (en) | Haemophilus parasuis polypeptides and methods of use | |
WO2011033506A3 (en) | Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage | |
WO2011123858A3 (en) | Ccn3 peptides and analogs thereof for therapeutic use | |
WO2016092555A3 (en) | Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage | |
WO2008148932A3 (en) | Glycosylasparaginase for treatment of cancers or inflammatory diseases | |
WO2008155363A3 (en) | Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof | |
WO2006123157A3 (en) | Nematistatic protein | |
WO2004041859A3 (en) | Peptide fragments of the harp factor inhibiting angiogenesis | |
WO2008109433A8 (en) | Anti-angiogenic peptides | |
WO2007073845A3 (en) | Polypeptide having esterase activity and recombinant esterase and use thereof | |
WO2012035322A3 (en) | A photocatalytic body | |
WO2006116789A3 (en) | Permeable capsules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10768078 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 218613 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2010768078 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010768078 Country of ref document: EP |